At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 32 enrolled
Drug / intervention
Hyaluronic acid gel (24 mg/mL) with 0.3% lidocaine +1 moredevice
Likely dose
Hyaluronic acid gel (24 mg/mL) with 0.3% lidocainefrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Juvederm Ultra With Lidocaine Compared With Restylane for the Correction of Nasolabial Folds
In Brief
A Phase 4 clinical trial evaluating Hyaluronic acid gel (24 mg/mL) with 0.3% lidocaine and A gel of hyaluronic acid (concentration of 20 mg/mL) for Nasolabial Folds. Completed, enrolled 32 participants across 1 site.
Detailed Summary
Comparison of the safety and effectiveness of Juvederm Ultra with lidocaine compared with Restylane in the correction of nasolabial folds.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNasolabial Folds
CountriesCanada
Collaborators--
Timeline
Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2008
Primary CompletionNov 2008
First PostedFeb 2009
TodayJul 2026
First PostedFeb 25, 2009
Enrollment StartNov 1, 2008
Primary CompletionNov 1, 2008
TodayJul 2, 2026
Enrollment to primary: 0 daysPosted 17.4 years ago
Interventions
Hyaluronic acid gel (24 mg/mL) with 0.3% lidocainedevice
Day 0, maximum total volume (dosage) allowed for each NLF is 1.6 mL
A gel of hyaluronic acid (concentration of 20 mg/mL)device
Day 0, maximum total volume (dosage) allowed for each NLF is 1.6 mL